LTC1758609I2 - Vakcina prieš HPV16 ir HPV18 ir mažiausiai vieną kitą HVP tipą, parinktą iš HVP 31,45 arba 52 - Google Patents

Vakcina prieš HPV16 ir HPV18 ir mažiausiai vieną kitą HVP tipą, parinktą iš HVP 31,45 arba 52

Info

Publication number
LTC1758609I2
LTC1758609I2 LTPA2015046C LTPA2015045C LTC1758609I2 LT C1758609 I2 LTC1758609 I2 LT C1758609I2 LT PA2015046 C LTPA2015046 C LT PA2015046C LT PA2015045 C LTPA2015045 C LT PA2015045C LT C1758609 I2 LTC1758609 I2 LT C1758609I2
Authority
LT
Lithuania
Prior art keywords
hvp
hpv18
type
vaccine against
against hpv16
Prior art date
Application number
LTPA2015046C
Other languages
English (en)
Lithuanian (lt)
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/114,301 external-priority patent/US20050287161A1/en
Priority claimed from PCT/EP2005/006461 external-priority patent/WO2005123125A1/en
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Publication of LTC1758609I2 publication Critical patent/LTC1758609I2/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
LTPA2015046C 2004-06-16 2015-12-07 Vakcina prieš HPV16 ir HPV18 ir mažiausiai vieną kitą HVP tipą, parinktą iš HVP 31,45 arba 52 LTC1758609I2 (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0413510.9A GB0413510D0 (en) 2004-06-16 2004-06-16 Vaccine
US11/114,301 US20050287161A1 (en) 2002-12-20 2005-04-26 Vaccine
PCT/EP2005/006461 WO2005123125A1 (en) 2004-06-16 2005-06-14 Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52

Publications (1)

Publication Number Publication Date
LTC1758609I2 true LTC1758609I2 (lt) 2017-05-10

Family

ID=32750044

Family Applications (1)

Application Number Title Priority Date Filing Date
LTPA2015046C LTC1758609I2 (lt) 2004-06-16 2015-12-07 Vakcina prieš HPV16 ir HPV18 ir mažiausiai vieną kitą HVP tipą, parinktą iš HVP 31,45 arba 52

Country Status (15)

Country Link
JP (1) JP2012102132A (nl)
KR (1) KR101359943B1 (nl)
CN (1) CN1976718B (nl)
CY (1) CY1113830T1 (nl)
DK (1) DK1758609T3 (nl)
ES (1) ES2394448T3 (nl)
GB (1) GB0413510D0 (nl)
HR (1) HRP20120930T1 (nl)
HU (3) HUS1500061I1 (nl)
LT (1) LTC1758609I2 (nl)
NL (3) NL300773I2 (nl)
PT (1) PT1758609E (nl)
SI (1) SI1758609T1 (nl)
TW (1) TW200612983A (nl)
ZA (1) ZA200610057B (nl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107080833A (zh) * 2009-04-10 2017-08-22 约翰·霍普金斯大学 作为广谱人类乳头状瘤病毒（hpv）疫苗的乳头状瘤病毒样颗粒（vlp）
WO2012006727A1 (en) * 2010-07-15 2012-01-19 British Columbia Cancer Agency Branch Human papillomavirus e7 antigen compositions and uses thereof
CN107188966B (zh) 2016-03-15 2020-03-31 中国医学科学院基础医学研究所 一种乳头瘤病毒嵌合蛋白及其用途
CN114539365B (zh) * 2020-11-26 2023-12-01 中国医学科学院基础医学研究所 一种改造的人乳头瘤病毒52型l1蛋白及其用途
CN114716560B (zh) 2021-01-04 2024-02-02 中国医学科学院基础医学研究所 一种人乳头瘤病毒18型嵌合蛋白及其用途
CN114716561B (zh) 2021-01-04 2024-03-12 中国医学科学院基础医学研究所 一种人乳头瘤病毒31型嵌合蛋白及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
GB9921147D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
GB0110431D0 (en) * 2001-04-27 2001-06-20 Glaxosmithkline Biolog Sa Novel compounds
GB0206360D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
GB0206359D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens

Also Published As

Publication number Publication date
HUS1500061I1 (hu) 2016-01-28
PT1758609E (pt) 2012-12-21
NL300771I2 (nl) 2015-12-29
NL300773I1 (nl) 2015-12-29
HUS1500060I1 (hu) 2017-10-30
NL300774I2 (nl) 2015-12-29
DK1758609T3 (da) 2012-12-10
ZA200610057B (en) 2008-02-27
HRP20120930T1 (hr) 2012-12-31
CY1113830T1 (el) 2016-06-22
NL300771I1 (nl) 2015-12-29
KR20120123617A (ko) 2012-11-08
NL300773I2 (nl) 2015-12-29
GB0413510D0 (en) 2004-07-21
NL300774I1 (nl) 2015-12-29
HUS1500059I1 (hu) 2017-10-30
TW200612983A (en) 2006-05-01
JP2012102132A (ja) 2012-05-31
ES2394448T3 (es) 2013-01-31
CN1976718B (zh) 2012-10-10
KR101359943B1 (ko) 2014-02-10
SI1758609T1 (sl) 2013-01-31
CN1976718A (zh) 2007-06-06

Similar Documents

Publication Publication Date Title
LTC1758609I2 (lt) Vakcina prieš HPV16 ir HPV18 ir mažiausiai vieną kitą HVP tipą, parinktą iš HVP 31,45 arba 52
BR0318327B1 (pt) garra cirérgica.
CY1111552T1 (el) Χρηση hpv16 και hpv18 ως εμβολιο εναντι ενος ή περισσοτερων ογκογονικου hpv τυπου 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
NO20052149D0 (no) Vaksine.
EA200701918A1 (ru) Белок липокалин
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
EA200600498A1 (ru) Макроциклические пептиды, проявляющие противовирусную активность в отношении вируса гепатита с
ITMI20032377A1 (it) Copolimeri del tfe.
NO20040632L (no) 2-amino-4,5-trisubstituerte tiazolylderivater.
NO20053348D0 (no) Farmasoytisk sammensetning for behandling av virusangrep.
DK1751276T3 (da) Vaccine omfattende en svækket pestvirus
ZA200509979B (en) Avian E. coli vaccine for the protection against colibacillosis
WO2007019373A3 (en) Novel formulations comprising fenofibrate and a statin, and related methods of treatment
FR15C0084I2 (fr) Vaccin contre les virus hpv16 et hpv18 et au moins un autre type de hpv selectionne parmi hpv 31, 45 ou 52
WO2004091524A3 (en) Respiratory virus vaccines
JP2006512078A5 (nl)
WO2007076091A3 (en) Treatment of viral infections using a tissue factor inhibitor
CY2015048I2 (el) Εμβολιο εναντι hpv16 και hpv18 και τουλαχιστον ενος αλλου τυπου hpv ο οποιος επιλεγεται απο hpv 31,45 ή 52
WO2005014629A3 (en) Protein from photobacterium damselae and use thereof
WO2007115686A3 (de) Verwendung von 3-(2,4,6-trimethylphenyl)-4-neopentylcarbonyloxy-5,5-tetramethylen-δ3-dihydrofuran-2-on zur bekämpfung von dipteren aus der familie der cecidomyiidae
WO2007081365A3 (en) Multiple antigenic agents and methods for using the same
WO2007038395A3 (en) Use of ephrinb2 directed agents for the treatment or prevention of viral infections
WO2006052820A3 (en) Human immunodeficiency virus vaccine
Moktan Book of oral recitations and moral teachings
AP2006003576A0 (en) Entry inhibitors of the HIV virus.